跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,036 条关于
“Metabolic Associated Steatohepatitis”
全部
32,036
临床试验
19,750
药物
499
机构
146
资讯
11,641
2年前
Madrigal's Resmetirom Nears Full Approval for NASH Cirrhosis Treatment Following Phase 3 Enrollment Completion
去年
AI-Based Pathology Tool Validated for Scoring Metabolic Dysfunction-Associated Steatohepatitis
去年
Multi-biotics Enhance Lenvatinib Sensitivity in MASH-Related HCC Organoids
7年前
FDA Approves Resmetirom (Rezdiffra) for Treating MASH and Associated Fibrosis
去年
EMA Endorses AI-Powered Pathology Tool to Enhance MASH Clinical Trial Accuracy
去年
Lanifibranor Shows Promise in MASH Patients with Type 2 Diabetes: LEGEND Trial Results
去年
Sagimet's Denifanstat Receives FDA Breakthrough Therapy Designation for MASH
去年
Pfizer's Novel MASH Treatment Combination Clesacostat/Ervogastat Projects $16M Revenue by 2036
去年
Sagimet Biosciences to Present Denifanstat's Anti-Fibrotic Effects in MASH at MASH-TAG 2025
去年
Sagimet's Denifanstat Receives FDA Breakthrough Therapy Designation for MASH
第 1 页，共 1165 页
上一页
下一页
